Steering Committee

  • Matthew Baumgart

  • Joshua Berry, MPH

  • Benjamin Bluml, RPh

  • Cesar Cerezo, MD, PhD

  • Steven Chen, PharmD, FASHP, FCSHP, FNAP

  • Hae Mi Choe, PharmD

  • John Clymer

    John Clymer is executive director of the National Forum for Heart Disease & Stroke Prevention, an independent, nonprofit catalyst for collaboration. Additionally, he is an adjunct assistant professor at Loma Linda University School of Public Health, guest lecturer at Johns Hopkins Bloomberg School of Public Health, and member of the U.S. Community Preventive Services Task Force.
    Under his leadership as president of Partnership for Prevention from 2001-2008, the organization won passage of landmark Medicare policy changes; established the National Commission on Prevention Priorities; was recognized by Harvard Business Review for a Breakthrough Idea on workforce health; and quadrupled its income.

    Clymer is the TEDMED thought leader for Great Challenges: Making Prevention Popular and Profitable and has served as a subject matter expert at the World Economic Forum’s Annual Meeting in Davos. He has conducted numerous Congressional briefings, appeared on NBC Nightly News, Fox News, CNBC, public radio, and in print media such as The New York Times, and authored book chapters, articles and commentaries on prevention.

  • Maria Delgado-Lelievre, MD

  • Rachel Ferencik, MPA

  • Scott Flinn, MD

    Dr. Flinn is a Regional Medical Director at Blue Shield of California where he focuses on improving the value of care delivered to Blue Shield members. Previously, Dr. Flinn was the Chief Medical Officer at Arch Health Partners, an award-winning medical group in San Diego. Prior to joining Arch, he served 22 years in the US Navy including two tours with the Navy SEALs, a tour as Medical Director for primary care at Naval Hospital San Diego, and a tour as Force Surgeon for Naval Surface Forces in charge of the health care for all Navy ships worldwide. A graduate of the University of Pittsburgh Medical School, Dr. Flinn is a member of the American Academy of Family Practice and the American College of Physician Executives, becoming a Certified Physician Executive in 2013. He is board certified in Family Practice with a CAQ in Sports Medicine.

  • Andrew Freeman, MD, FACC, FACP

  • Brigid K. Groves, PharmD, MS

    Brigid K Grove 1s Senior Director, Practice and Professional Affairs at the American Pharmacists Association (APhA). She leads, coordinates, and contributes to efforts and initiatives related to transformation of the role of the pharmacist, advancing pharmacists’ patient care services, creation of practice tools and resources, and promoting the pharmacist’s role as a health care provider. Additionally, she administers, directs, coordinates, and participates in the work of the Association related to the APhA Community-based Pharmacy Residency Program initiative and advancement of postgraduate pharmacy residency education and training initiatives. Previously, Groves was population health pharmacist at a pediatric accountable care organization. Prior, she held roles as a clinical and pharmacy practice coordinator at a large grocery-store based community pharmacy chain. Groves has been heavily involved in professional pharmacy organizations for many years.

    Groves earned her Master of Science in Pharmacy Administration in 2014 and her PharmD in 2012 at The Ohio State University College of Pharmacy (OSU COP). Additionally, she completed a combined PGY1 and PGY2 pharmacy residency in community care pharmacy administration at Kroger Pharmacy and OSU COP in 2014. Before her PharmD, Groves earned her Bachelor of Science in Chemistry in 2006 from John Carroll University, Cleveland, Ohio.

  • Laura King, BScN

  • Marti Macchi, MEd, MPH

  • Keiva Nelson

    Keiva Nelson serves as a Team Lead Public Health Advisor, with over 13 years of Federal Service, for the HHS Office of the Assistant Secretary for Health, Office on Women’s Health (OWH), Division of Policy and Performance Management. In this capacity, she has managed and overseen several projects, working towards achieving the vision and mission of OWH. Keiva represents OWH on several collaborations and workgroups, such as the Million Hearts Partnership with CDC, HRSA’s National Hypertension Control Initiative (NHCI), and the Federal Hypertension Control Leadership Council. Keiva is also the Project Lead for the design, building, and implementation of the new Performance Management Data Collection System, a data collection and analysis system to capture OWH’s performance measure reporting requirements, providing program data that generates trends and status updates for strategic planning accomplishments. Her leadership and oversight on this project led to Keiva being a recipient of the 2022 HHS Unsung Hero Award, from the HHS Assistant Secretary for Health.

  • Eduardo Sanchez, MD, MPH

    Dr. Sanchez serves as Chief Medical Officer (CMO) for Prevention for the American Heart Association (AHA). He is the Principal Investigator of the National Hypertension Control Initiative with the federal Office of Minority Health and the Health Resources and Services Administration. He is the AHA clinical lead on Target: BP (a joint blood pressure control initiative with the American Medical Association) and Know Diabetes by Heart (a joint cardiovascular risk factor control initiative with the American Diabetes Association). Before joining AHA, he served as Vice President and CMO for Blue Cross and Blue Shield of Texas, and he served as director of the Institute for Health Policy at the University of Texas School of Public Health. Dr. Sanchez served as Commissioner of the Texas Department of State Health Services from 2004 to 2006 and Commissioner of the Texas Department of Health. Dr. Sanchez obtained his MD from the University of Texas (UT) Southwestern Medical School in Dallas, an MPH from the UT Health Science Center at Houston School of Public Health, and an MS in biomedical engineering from Duke University. Dr. Sanchez is board certified in family medicine.

  • Miriam Patanian, MPH

    Miriam Patanian has more than 20 years of public health experience focused on chronic disease prevention and control at both the state and national levels. She is a senior public health consultant at NACDD, leading health system initiatives addressing hypertension, Million Hearts®, and cardiovascular health. Before working as a consultant, Ms. Patanian served as the Director of the Heart Disease and Stroke Prevention Program at the Washington State Department of Health. During this time, she coordinated local and statewide implementation of evidence-based initiatives to increase hypertension control and reduce the burden of heart disease and stroke in the state. Ms. Patanian began her public health career at the Centers for Disease Control and Prevention in the Cardiovascular Health Branch (before it became the Division for Heart Disease and Stroke Prevention), where she helped to develop the Public Health Action Plan to Prevent Heart Disease and Stroke. She received her MPH from the University of Washington.

  • Modele O. Ogunniyi, MD, MPH, FACC, FACP, FAHA

    Dr. Modele Ogunniyi is an Associate Professor of Medicine and Master Physician with the Division of Cardiology at Emory University School of Medicine. She also serves as the Associate Medical Director of the Grady Heart Failure Program.

    After receiving her medical degree from the University of Ibadan, Nigeria, she obtained a Masters of Public Health and a Certificate in Health Finance and Management from Johns Hopkins University. Her postgraduate training includes a preventive medicine and public health fellowship at the Centers for Disease Control and Prevention, residency in internal medicine at Morehouse School of Medicine and cardiology fellowship at Vanderbilt University.

    Her research focuses on examining social determinants of health and eliminating disparities in cardiovascular disease, specifically, hypertension and heart failure; and more recently, diversity in clinical trials, palliative care in advanced heart failure and cardiovascular disease in women. As a cardiovascular epidemiologist, she seeks to forge links between preventive medicine, public policy, quality improvement and scientific research. She is very passionate about mentorship, growing the pipeline and diversifying the workforce in Medicine.

    Dr. Ogunniyi is Principal Investigator on several clinical trials. She serves on the advisory board for the Metro Atlanta Heart Failure Collaborative and the editorial board of Clinical Cardiology. She is an active member/volunteer of many professional organizations including the Association of Black Cardiologists (ABC), American Heart Association, American College of Cardiology (ACC) and American Medical Women’s Association. She is a Fellow of the American College of Physicians, American College of Cardiology, and American Heart Association.

    She serves on several national committees, including Co-Chair of the ABC Membership Committee, ACC Cardiovascular Disease in Women Committee, and the Steering Committee of the National Hypertension Control Roundtable. She is the Vice President of Health Awareness Initiative, Africa, a nonprofit organization, whose mission is to promote healthy lifestyles in African communities by creating health awareness through screening and education.

  • Nar Ramkissoon

    Nar Ramkissoon, MA leads collaborations, programs, and policy efforts to engage a broad set of ecosystem stakeholders to remove barriers for physicians, care teams, and patients and prevent cardiovascular disease prevention. His areas of expertise are in remote monitoring, medical devices and emerging technology, public and private insurance coverage, and payment. Key areas of focus for his team are increasing access to validated blood pressure devices and enabling physicians and patients to adopt self-measured blood pressure monitoring. Nar has a background in healthcare consulting and holds a Master of Public Health from DePaul University.

  • Kyu Rhee